For example, a study in 27 obese women receiving PT-141 showed a decrease in daily calorie intake by 400kcals and an average weight loss of 3.7lb over 16 days, surpassing the 2lb loss observed in the placebo group [9]
Ashley Koff, RD 00:32:29 Interesting because I so number one, I have some patients where and Im using it a low dose for experiences of disordered eating
The treatment, which operates by targeting glucagon-like peptide-1 (GLP-1) receptors, falls within a class of drugs that are designed to affect the bodys insulin production and blood sugar levels
They help to slow down how fast food leaves your stomach and tell your brain that you are full
Nucleic Acids Res [Internet]
As the market continues to evolve, stakeholders are presented with ample opportunities to shape the future of healthcare in chronic disease management